International Business News - Cypress http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of Cypress Semiconductor Corp. jumped Friday after the chip maker said it plans a convertible debt buyback--and its majority-owned subsidiary, SunPower Corp., was picked by a California utility for a large project. http://www.ibtimes.com/articles/20080815/cypress-semiconductor-jumps-after-sunpower-deal.htm Fri, 15 Aug 2008 16:59:33 EDT Drug developer Cypress Bioscience Inc. said Friday it swung to a loss in the second quarter, as revenue from collaborations fell sharply compared with a year ago. http://www.ibtimes.com/articles/20080808/cypress-swings-to-2q-loss-due-to-declining-revenue.htm Fri, 08 Aug 2008 08:42:51 EDT Chip maker Cypress Semiconductor Corp. said Friday it agreed to buy Simtek Corp. for $2.60 per share, or about $46 million in cash. The price includes the value of Simtek's shares--about 4 percent of them--that Cypress already owns. http://www.ibtimes.com/articles/20080801/cypress-semi-to-buy-simtek-for-46-million.htm Fri, 01 Aug 2008 16:40:41 EDT Cypress Semiconductor Corp. on Thursday reported second-quarter earnings above Wall Street estimates, although they fell sharply from a year ago when results were helped by a one-time gain from a sale. http://www.ibtimes.com/articles/20080717/cypress-semi-2q-earnings-fall-but-beat-street.htm Thu, 17 Jul 2008 09:29:45 EDT Shares of Cypress Semiconductor Corp. rose 5 percent Wednesday in anticipation of a strong second-quarter earnings report from the chip maker on Thursday. http://www.ibtimes.com/articles/20080716/cypress-semi-rises-5-percent-ahead-of-2q-earnings.htm Wed, 16 Jul 2008 19:40:15 EDT Shares of Cypress Bioscience Inc. surged Monday, as analysts said the Food and Drug Administration's approval of Eli Lilly & Co.'s antidepressant Cymbalta as a treatment for fibromyalgia bodes well for a similar Cypress drug. http://www.ibtimes.com/articles/20080616/cypress-bioscience-up-on-cymbalta-approval.htm Mon, 16 Jun 2008 14:20:44 EDT Shares of Cypress Semiconductor Corp. rose Friday as analysts were encouraged by presentations delivered by two of the chip maker's executives. Additionally, shares of solar power products maker SunPower Corp., which frequently drive Cypress stock, climbed $5.84, or 7.7 percent, to $81.84, rallying along with the entire solar sector. Cypress has a 52 percent stake in SunPower. http://www.ibtimes.com/articles/20080530/cypress-semi-rises-with-sunpower-analyst-praise.htm Fri, 30 May 2008 17:36:35 EDT Cypress Bioscience Inc. Monday said that its first-quarter loss widened on an increase in operating expenses stemming from the drug developer's acquisition of Propius Pharmaceuticals. http://www.ibtimes.com/articles/20080512/cypress-bioscience-1q-loss-widens-on-expenses.htm Mon, 12 May 2008 12:54:55 EDT The executive vice president of Cypress Semiconductor Inc. exercised options for 4,520 shares of common stock, according to a Securities and Exchange Commission filing Friday. http://www.ibtimes.com/articles/20080428/cypress-semiconductor-evp-exercises-options.htm Mon, 28 Apr 2008 15:24:50 EDT Shares of chip maker Cypress Semiconductor Corp. rose Friday on positive analyst reaction to its first-quarter results. The company reported profit above Wall Street expectations and signaled that i... http://www.ibtimes.com/articles/20080418/cypress-semiconductor-shares-rise-on-reaction-to-1q-results.htm Fri, 18 Apr 2008 14:20:46 EDT Shares of chip maker Cypress Semiconductor Corp. seesawed Thursday after it reported first-quarter sales above Wall Street expectations but a lower-than-forecast profit. It also signaled that it may... http://www.ibtimes.com/articles/20080417/cypress-semiconductor-shares-dip-on-1st-quarter-results.htm Thu, 17 Apr 2008 19:26:39 EDT Chip maker Simtek Corp. said Friday its board has rejected an unsolicited proposal by Cypress Semiconductor Corp. to buy the company as not in shareholders' best interests because it undervalues the... http://www.ibtimes.com/articles/20080411/simtek-rejects-cypress-semi-takeover-bid.htm Fri, 11 Apr 2008 18:37:44 EDT Cypress Bioscience Inc. said Monday it will acquire specialty drug maker Proprius Pharmaceuticals Inc. in a deal valued at up to about $75 million. Cypress aims to enhance its product offerings in the treatment of the pain disorder fibromyalgia and in rheumatoid arthritis. http://www.ibtimes.com/articles/20080225/cypress-bioscience-to-buy-proprius.htm Mon, 25 Feb 2008 09:09:04 EST Chip maker Cypress Semiconductor Corp. said Friday it has doubled the size of its stock repurchase program to $600 million. The authorization allows the company to purchase its common stock and some convertible senior notes or to enter into derivative transactions related to its common shares. http://www.ibtimes.com/articles/20080222/cypress-semiconductor-doubles-buyback.htm Fri, 22 Feb 2008 08:05:52 EST Simtek Corp., a provider of semiconductor memory products, said Friday it will consider a potential acquisition by chip maker Cypress Semiconductor Corp. and other transactions. http://www.ibtimes.com/articles/20080208/simtek-to-consider-cypress-offer.htm Fri, 08 Feb 2008 07:26:39 EST Drug developer Cypress Pharmaceutical Inc. said Friday it reached a settlement with a unit of British drug maker GlaxoSmithKline PLC related to a generic version of Glaxo's Zantac syrup to treat symptoms of heartburn. http://www.ibtimes.com/articles/20080125/cypress-pharma-glaxo-reach-settlement.htm Fri, 25 Jan 2008 10:38:15 EST Cypress Semiconductor Corp. said Wednesday it will sell or exit its manufacturing facility in Round Rock, Texas and transition production to its more "cost-competitive" Minnesota facility and outside third-party foundries _ eliminating 245 jobs in the process. http://www.ibtimes.com/articles/20071226/cypress-semi-to-cut-245-jobs.htm Wed, 26 Dec 2007 14:17:15 EST